Clinical Experience
Clinical Experience with over 1700 patients with Fetal Stem Cell Therapy in Ukraine
“In 2004, the prestigious Institute for Cryobiology and Cryomedicine in the Ukraine gathered data on the use of fetal liver cells and fetal neuronal cells for hematologic support and treatment of more than 1700 patients suffering from a wide variety of diseases and conditions, including blood and immune disorders, diabetes, eye disorders (e.g., diabetic retinopathy, macular degeneration), neurologic conditions (e.g., spinal cord injuries, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and others), hemosuppression due to chemotherapy or radiation therapy for various types of cancer, gynecologic problems, chronic fatigue syndrome, gastrointestinal disorders (e.g., ulcerative colitis, Crohn’s disease, and abdominal adhesions), and others. Overall, the responses to treatment were “significant” in 68%, “partial” in 28% and none in 4%. The follow-up periods were up to eight years.18 As can be seen in the Table, the various diseases generally responded well. Other reviews of the Institute for Cryobiology and Cryomedicine’s experience in treating a wide range of patients with various cell preparations note positive responses in about 70% to 80% of patients.”
Table: Summary of Clinical Experience with Fetal Stem Cell Therapy, Institute for Cryobiology and Cryomedicine, Ukraine
Institute for Cryobiology and Cryomedicine. Clinical applications of fetal
summary of findings. Unpublished report. Institute for Problems of Cryobiology
National Academy of Sciences of the Ukraine. Kharkov, Ukraine, 2004.
Want detailed stem cell educational information? If so be sure to click below to learn about Human Umbilical Cord Stem Cells, What are Stem Cells, Why are they important and how can they be used as preventive therapies, also learn about different sources and types of stem cells, and how they are separated and processed.
CLICK HERE for: Detailed Stem Cell Educational page
Ready to get your treatment? Click here for Treatment Center information
Ready to order your treatment? CLICK HERE for our product page
Click here to join our FORUMS 
Skype us now
NEW Signup to our FREE monthly newsletter
We are dedicated to bringing stem cell healing therapies to the world NOW!
USA ONLY: The mesenchymal and umbilical cord blood stem cells used in this study are human cells, tissues, or cellular and tissue-based products (HCT/Ps) as defined in 21 CFR § 1271.3(d). Under 21 CFR Part 1271, HCT/Ps are not subject to licensure or IND requirements if certain criteria are met (21 CFR § 1271.10). These requirements include autologous use (use by the cell donor), or if used for other patients, the HCT/Ps must be “not more than minimally manipulated” and labeled for use for “homologous use only”. They may also not be used for a purpose requiring their “metabolic” activity. StemLab S.A. mesenchymal and umbilical cord stem cells shipped to the United States of America have not been “more than minimally manipulated”. StemLab S.A. labels and intends its cells which are used within the United States of America only for homologous and non-metabolic purposes. StemLab S.A. does not interfere with the practice of medicine by individual physicians who use StemLab products, and who may do so according to their own medical training and informed choice.
StemTech Labs is a Global Genius Trust company